11 analysts have shared their evaluations of Insulet PODD during the recent three months, expressing a mix of bullish and ...

Citi raised the firm’s price target on Insulet to $310 from $283 and keeps a Buy rating on the shares as part of a 2025 outlook for the U.S.

OTR Global has a Positive read on Tandem Diabetes (TNDM) and Insulet (PODD) after interviews with U.S. endocrinology practitioners that showed ...

Pharmaceutical and biotech businesses were enthusiastic about the UPC before the court opened, but so far there has only been ...

A Cornerstone in Diabetes ManagementInsulin delivery devices market are innovative medical instruments designed to provide ...

Citi Research analysts updated their “SMID value creators” list, removing Globant . The “SMID Value Creators List” names buy-rated stocks by Citi analysts ...

The rebel leader who helped oust the Assad regime calls on countries to hand over “criminals” who fled Syria. A new caretaker prime minister warns that the country faces a dire financial ...

Christopher Wray Will Step Down as F.B.I. Director President-elect Trump had already signaled his intention to replace Mr. Wray with a longtime loyalist, Kash Patel. U.S. Colleges Warn Foreign ...

Covering Netflix News Independently Since 2013. What’s on Netflix is not owned by or affiliated with Netflix or any of its partners in any capacity. The authors of this site also have no affiliation ...